COL4A1 mutation in an Indian child presenting as ‘Cerebral Palsy’ mimic

Abstract

The COL4A1 gene (COL4A1) plays an important role in vascular basement membrane function and pathogenic mutations have been reported in mice and humans. The gene is expressed mainly in the human brain, eyes and kidneys. Pathogenic mutations result in a vast array of manifestations that can present throughout life including the foetal period. We present a case of an 11-year-old girl with right hemiparesis, congenital cataracts, epilepsy and magnetic resonance imaging (MRI) brain findings with a pathogenic COL4A1 mutation. Many of her clinical features are similar to those of a non-genetic cause of cerebral palsy highlighting the difficulties and delays in making this genetic diagnosis.

Keywords

Cerebral palsy - COL4A1 gene mutation - epilepsy; gliosis - magnetic resonance imaging - paediatric congenital cataract

Publikationsverlauf

Eingereicht: 18. April 2020

Angenommen: 30. Oktober 2020

Artikel online veröffentlicht:
14. Juli 2021

• References

• 1 Gould DB, Phalan FC, Breedveld GJ, van Mil SE, Smith RS, Schimenti JC. et al. Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly. Science 2005; 308: 1167-71
• 2 Plaisier E, Gribouval O, Alamowitch S, Mougenot B, Prost C, Verpont MC. et al. COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. N Engl J Med 2007; 357: 2687-95
• 3 Yoneda Y, Haginoya K, Kato M, Osaka H, Yokochi K, Arai H. et al. Phenotypic spectrum of COL4A1 mutations: Porencephaly to schizencephaly. Ann Neurol 2013; 73: 48-57
• 4 de Vries LS, Koopman C, Groenendaal F, Van Schooneveld M, Verheijen FW, Verbeek E. et al. COL4A1 mutation in two preterm siblings with antenatal onset of parenchymal hemorrhage. Ann Neurol 2009; 65: 12-8
• 5 Shah S, Ellard S, Kneen R, Lim M, Osborne N, Rankin J. et al. Childhood presentation of COL4A1 mutations. Dev Med Child Neurol 2012; 54: 569-74
• 6 Shah S, Kumar Y, McLean B, Churchill A, Stoodley N, Rankin J. et al. A dominantly inherited mutation in collagen IV A1 (COL4A1) causing childhood onset stroke without porencephaly. Eur J Paediatr Neurol 2010; 14: 182-7
• 7 Zagaglia S, Selch C, Nisevic JR, Mei D, Michalak Z, Hernandez-Hernandez L. et al. Neurologic phenotypes associated with COL4A1/2 mutations: Expanding the spectrum of disease. Neurology 2018; 91: e2078-88
• 8 Yoneda Y, Haginoya K, Arai H, Yamaoka S, Tsurusaki Y, Doi H. et al. De novo and inherited mutations in COL4A2, encoding the type IV collagen a2 chain cause porencephaly. Am J Hum Genet 2012; 90: 86-90
• 9 Nandeesh BN, Bindu PS, Narayanappa G, Yasha TC, Mahadevan A, Kulanthaivelu K. et al. Cerebral small vessel disease with hemorrhagic stroke related to COL4A1 mutation: A case report. Neuropathology 2020; 40: 93-8
• 10 Kitzler TM, Schneider R, Kohl S, Kolvenbach CM, Connaughton DM, Dai R. et al. COL4A1 mutations as a potential novel cause of autosomal dominant CAKUT in humans. Hum Genet 2019; 138: 1105-15
• 11 Lanfranconi S, Markus HS. COL4A1 mutations as a monogenic cause of cerebral small vessel disease: A systematic review. Stroke 2010; 41: e513-8
• 12 Vahedi K, Alamowitch S. Clinical spectrum of type IV collagen (COL4A1) mutations: A novel genetic multisystem disease. Curr Opin Neurol 24: 63-8
• 13 Renard D, Minè M, Pipiras E, Labauge P, Delahaye A, Benzacken B. et al. Cerebral small-vessel disease associated with COL4A1 and COL4A2 gene duplications. Neurology 2014; 83: 1029-31
• 14 Lemmens R, Maugeri A, Niessen HW, Goris A, Tousseyn T, Demaerel P. et al. Novel COL4A1 mutations cause cerebral small vessel disease by haploinsufficiency. Hum Mol Genet 2013; 22: 391-7
• 15 Van Der Knaap MS, Smit LME, Barkhof F, Pijnenburg YA, Zweegman S, Niessen HW. et al. Neonatal porencephaly and adult stroke related to mutations in collagen IV A1. Ann Neurol 2006; 59: 504-11